• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Ulta Beauty Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

    4/3/24 1:56:10 PM ET
    $ABAT
    $ABIO
    $ACOR
    $ADXN
    Metal Mining
    Basic Materials
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care
    Get the next $ABAT alert in real time by email

    Shares of Ulta Beauty, Inc. (NASDAQ:ULTA) fell sharply during Wednesday’s session amid the company's presentation at the J.P. Morgan Retail Roundup investor conference where the company reportedly issued a weak outlook.

    Ulta Beauty shares dipped 13.7% to $448.08 on Wednesday.

    Here are some other stocks moving in today's mid-day session.

    Gainers

    • ARCA biopharma, Inc. (NASDAQ:ABIO) climbed 108% to $3.5549 after the company and Oruka Therapeutics announced a merger agreement.
    • Kintara Therapeutics, Inc. (NASDAQ:KTRA) shares gained 89% to $0.1906 after the company entered a merger agreement with TuHURA Biosciences.
    • Next Technology Holding Inc. (NASDAQ:NXTT) rose 57.4% to $6.42.
    • Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) shares climbed 39.3% to $5.45. Vanda Pharmaceuticals' Fanapt® received U.S. FDA approval for the acute treatment of Bipolar I Disorder.
    • VivoPower International PLC (NASDAQ:VVPR) shares gained 39% to $8.20 after the company declared a capital management strategy including a stock buyback program of up to $5 million.
    • Next.e.GO N.V. (NASDAQ:EGOX) gained 32.7% to $0.0345.
    • XTI Aerospace, Inc. (NASDAQ:XTIA) rose 32.2% to $4.63. BestGrowthStocks.com issued comprehensive evaluation of XTI Aerospace, Inc.
    • Brooge Energy Limited (NASDAQ:BROG) gained 28.8% to $3.0790.
    • Addex Therapeutics Ltd (NASDAQ:ADXN) rose 24.6% to $16.21 after the company and funds affiliated with Perceptive Advisors announced the launch of Neurosterix.
    • Aesthetic Medical International Holdings Group Limited (NASDAQ:AIH) gained 24.3% to $0.3981 after gaining 13% on Tuesday.
    • LAMF Global Ventures Corp. I (NASDAQ:LGVC) gained 22.7% to $13.21. ViewLAMF Global Ventures Corp. I shareholders approved previously announced business combination with Nuvo Group Ltd.
    • Quhuo Limited (NASDAQ:QH) rose 21.7% to $0.6501 after reporting unaudited financial results for the second half and full year 2023.
    • Destiny Tech100 Inc. (NYSE:DXYZ) gained 21.4% to $25.77.
    • OneMedNet Corporation (NASDAQ:ONMD) gained 21.2% to $0.9600. OneMedNet announced it entered a securities purchase agreement dated Mar. 28 providing up to $4.54 million in funding through private placement of senior convertible notes.
    • CXApp Inc. (NASDAQ:CXAI) gained 20.5% to $5.40 following a massive rally to start the week. CXApp shares rallied more than 150% to start the week after the company announced a partnership with Alphabet’s Google Cloud.
    • Clean Energy Technologies, Inc. (NASDAQ:CETY) climbed 20.5% to $1.63.
    • American Battery Technology Company (NASDAQ:ABAT) rose 17.7% to $1.9301. American Battery Technology Company was awarded $20 million tax credit through competitive U.S. DOE process to advance its critical minerals battery recycling facility.
    • C3is Inc. (NASDAQ:CISS) shares rose 14.9% to $0.0470 after gaining 13% on Tuesday. On March 26, C3is reported a year-over-year increase in fourth-quarter financial results.
    • Pyxis Oncology, Inc. (NASDAQ:PYXS) gained 12.3% to $6.04.
    • Atai Life Sciences N.V. (NASDAQ:ATAI) surged 11.4% to $2.08. Maxim Group analyst Jason McCarthy upgraded ATAI Life Sciences from Hold to Buy and announced a $6 price target.
    • Dave & Buster's Entertainment, Inc. (NASDAQ:PLAY) shares rose 10.2% to $68.22 after the company reported fourth quarter results.
    • Esperion Therapeutics, Inc. (NASDAQ:ESPR) jumped 9.7% to $3.16.
    • Signet Jewelers Limited (NYSE:SIG) gained 9.2% to $103.80after the company raised its FY25 guidance.
    • Inspire Veterinary Partners, Inc. (NASDAQ:IVP) gained 9% to $0.0512. On Jan. 5, Inspire Veterinary Partners filed a prospectus related to up to a $5 million public offering.
    • Semtech Corporation (NASDAQ:SMTC) gained 7.4% to $30.28.
    • Cal-Maine Foods, Inc. (NASDAQ:CALM) climbed 6.8% to $62.88 after the company reported upbeat results for its fourth quarter.

    Losers

    • Casa Systems, Inc. (NASDAQ:CASA) shares dipped 78.1% to $0.0563 after the Company filed voluntary petitions for relief under Chapter 11 of the Bankruptcy Code in the U.S. Bankruptcy Court.
    • View, Inc. (NASDAQ:VIEW) fell 61.9% to $0.4196 after the company filed for Chapter 11 bankruptcy. The company on Tuesday said it reached a real with Cantor Fitzgerald and RXR to become a private company.
    • Sintx Technologies, Inc. (NASDAQ:SINT) fell 44.5% to $0.0232 after the company announced pricing of a $1.5 million public offering of common stock.
    • GCT Semiconductor Holding, Inc. (NYSE:GCTS) dipped 40% to $9.29 amid volatility following the company's recently completed business combination with Concord Acquisition Corp III and NYSE debut.
    • FibroGen, Inc. (NASDAQ:FGEN) fell 32.8% to $1.4499. FibroGen announced topline data from the Fortis Therapeutics-sponsored Phase 1 study of FG-3246 (also known as FOR46), a potential first-in-class anti-CD46 antibody drug conjugate (ADC) with an MMAE-containing payload.
    • Keyarch Acquisition Corporation (NASDAQ:KYCH) fell 28.5% to $9.65.
    • TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) dipped 24.2% to $0.3148 as the company issued an update on ongoing ENVASARC Phase 2 pivotal trial following Independent Data Monitoring Committee Recommendation to continue the trial as planned.
    • BYND Cannasoft Enterprises Inc. (NASDAQ:BCAN) fell 22.5% to $0.9741 after dipping around 12% on Tuesday.
    • Anghami Inc. (NASDAQ:ANGH) fell 22.2% to $1.40. Anghami recently announced that it completed its transaction with OSN+.
    • Locafy Limited (NASDAQ:LCFY) dipped 21.9% to $3.67 following second-quarter results.
    • Vicinity Motor Corp. (NASDAQ:VEV) fell 19.3% to $0.75 after the company reported a year-over-year decrease in fourth-quarter EPS results.
    • Enveric Biosciences, Inc. (NASDAQ:ENVB) dipped 18.4% to $0.93.
    • Murano Global Investments Plc (NASDAQ:MRNO) fell 16.8% to $10.39.
    • Critical Metals Corp. (NASDAQ:CRML) fell 16.7% to $11.66.
    • Acorda Therapeutics, Inc. (NASDAQ:ACOR) shares fell 12% to $2.20. Acorda Therapeutics shares dipped 81% on Tuesday after the company commenced voluntary proceedings under Chapter 11 of the United States Bankruptcy Code.
    • Exscientia plc (NASDAQ:EXAI) fell 10.8% to $4.6395 following quarterly results.
    • Gamida Cell Ltd. (NASDAQ:GMDA) shares fell 8.4% to $0.0403 after gaining 18% on Tuesday.
    • e.l.f. Beauty, Inc. (NYSE:ELF) fell 8.2% to $170.71 after peer Ulta Beauty reportedly issued weak guidance at a conference.
    • NWTN Inc. (NASDAQ:NWTN) fell 8% to $7.21.
    • Mesoblast Limited (NASDAQ:MESO) shares tumbled 7.3% to $6.11 after gaining 8% on Tuesday.
    • Applied Digital Corporation (NASDAQ:APLD) fell 6.1% to $3.5850.
    • Lands' End, Inc. (NASDAQ:LE) fell 6.1% to $11.25.
    • Intel Corporation (NASDAQ:INTC) fell 6.1% to $41.27 after the company outlined a new financial framework for its foundry business. After the market close on Tuesday, Intel announced a new financial reporting structure designed to drive increased cost discipline and higher returns by providing greater transparency, accountability and incentives across the business.

     

    Now Read This: Ethereum Trades Below $3,400 Following ADP Report; Stacks Becomes Top Loser

    Get the next $ABAT alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ABAT
    $ABIO
    $ACOR
    $ADXN

    CompanyDatePrice TargetRatingAnalyst
    e.l.f. Beauty Inc.
    $ELF
    4/3/2026$68.00In-line
    Evercore ISI
    e.l.f. Beauty Inc.
    $ELF
    4/2/2026$68.00In-line
    Evercore ISI
    AtaiBeckley Inc.
    $ATAI
    3/27/2026$12.00Buy
    Deutsche Bank
    Ulta Beauty Inc.
    $ULTA
    3/9/2026$640.00 → $715.00Outperform
    Telsey Advisory Group
    Vanda Pharmaceuticals Inc.
    $VNDA
    3/5/2026$18.00Buy
    Truist
    Ulta Beauty Inc.
    $ULTA
    2/20/2026$647.00 → $800.00Strong Buy
    Raymond James
    Intel Corporation
    $INTC
    2/13/2026$45.00Neutral
    DA Davidson
    e.l.f. Beauty Inc.
    $ELF
    1/23/2026$110.00Buy
    Citigroup
    More analyst ratings

    $ABAT
    $ABIO
    $ACOR
    $ADXN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Lyons Christopher Michael bought $24,092 worth of shares (8,292 units at $2.91) (SEC Form 4)

    4 - Sintx Technologies, Inc. (0001269026) (Issuer)

    3/10/26 9:00:18 AM ET
    $SINT
    Medical/Dental Instruments
    Health Care

    Director Moyes Jay M bought $2,910 worth of shares (1,000 units at $2.91), increasing direct ownership by 33% to 4,000 units (SEC Form 4)

    4 - Sintx Technologies, Inc. (0001269026) (Issuer)

    2/25/26 9:00:02 AM ET
    $SINT
    Medical/Dental Instruments
    Health Care

    Director Farrell Matthew bought $464,814 worth of shares (5,000 units at $92.96), increasing direct ownership by 86% to 10,820 units (SEC Form 4)

    4 - e.l.f. Beauty, Inc. (0001600033) (Issuer)

    2/23/26 4:07:34 PM ET
    $ELF
    Package Goods/Cosmetics
    Consumer Discretionary

    $ABAT
    $ABIO
    $ACOR
    $ADXN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Quhuo Reports Financial Results for the Second Half and Full Year 2025

    BEIJING, April 2, 2026 /PRNewswire/ -- Quhuo Limited (NASDAQ:QH) ("Quhuo," the "Company," "we" or "our"), a leading gig economy platform focusing on local life services in China, today reported its unaudited financial results for the six months and full year ended December 31, 2025. Financial and Operational Highlights for the Second Half of 2025Revenues from housekeeping and accommodation solutions and other services were RMB45.7 million (US$6.5 million), representing a year-over-year increase of 99.8% from RMB22.9 million.Gross profit of vehicle export solutions was RMB12.6 million (US$1.8 million), representing a year-over-year increase of 327.9% from RMB2.9 million.Gross profit of housek

    4/2/26 4:10:00 PM ET
    $QH
    Real Estate

    Intel Appoints Aparna Bawa as Executive Vice President and Chief Legal & People Officer

    Intel Corporation today announced the appointment of Aparna Bawa as EVP, chief legal & people officer. Bawa will report directly to CEO Lip-Bu Tan and will lead Intel's global legal, ethics, compliance, people, and culture organizations as the company accelerates its transformation and execution agenda. "The role of legal and people leadership has never been more critical as Intel drives cultural transformation with discipline, speed, and integrity," said Intel CEO Lip-Bu Tan. "Aparna brings a rare combination of operational rigor, business judgment, and people-first leadership. Her experience helping scale global technology companies through periods of significant change will be invaluab

    4/2/26 4:05:00 PM ET
    $INTC
    Semiconductors
    Technology

    Athyrium Capital Management and Esperion Enter Into $50 Million Japan Royalty Financing to Support Strategic Acquisition of Corstasis Therapeutics

    Athyrium Funds purchased a portion of the royalties payable to Esperion on Japan net sales of Otsuka's bempedoic acid products, together with related milestone payments, subject to a cap, for total consideration of $50 millionAthyrium Funds to receive tiered royalties ranging from 12% to 33%, as well as milestone payments, until receiving aggregate payments equal to 2.0x their investment, after which all rights revert to EsperionFinancing supports Esperion's acquisition of Corstasis Therapeutics Inc., which developed and is commercializing Enbumyst™, the first FDA-approved intranasal loop diuretic for treatment of edema associated with cardiovascular and hepatic and renal disease NEW YORK a

    4/2/26 4:05:00 PM ET
    $ESPR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABAT
    $ABIO
    $ACOR
    $ADXN
    SEC Filings

    View All

    SEC Form PRE 14A filed by Enveric Biosciences Inc.

    PRE 14A - Enveric Biosciences, Inc. (0000890821) (Filer)

    4/3/26 5:05:48 PM ET
    $ENVB
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form PRE 14A filed by Ulta Beauty Inc.

    PRE 14A - Ulta Beauty, Inc. (0001403568) (Filer)

    4/3/26 4:55:02 PM ET
    $ULTA
    Other Specialty Stores
    Consumer Discretionary

    Intel Corporation filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K - INTEL CORP (0000050863) (Filer)

    4/3/26 12:50:37 PM ET
    $INTC
    Semiconductors
    Technology

    $ABAT
    $ABIO
    $ACOR
    $ADXN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Melsert Ryan Mitchell

    4 - AMERICAN BATTERY TECHNOLOGY Co (0001576873) (Issuer)

    4/3/26 4:00:24 PM ET
    $ABAT
    Metal Mining
    Basic Materials

    SEC Form 4 filed by Jolcover Scott

    4 - AMERICAN BATTERY TECHNOLOGY Co (0001576873) (Issuer)

    4/3/26 4:00:26 PM ET
    $ABAT
    Metal Mining
    Basic Materials

    SEC Form 4 filed by Lialios Christopher

    4 - Ulta Beauty, Inc. (0001403568) (Issuer)

    4/2/26 8:25:36 PM ET
    $ULTA
    Other Specialty Stores
    Consumer Discretionary

    $ABAT
    $ABIO
    $ACOR
    $ADXN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Evercore ISI initiated coverage on e.l.f. Beauty with a new price target

    Evercore ISI initiated coverage of e.l.f. Beauty with a rating of In-line and set a new price target of $68.00

    4/3/26 10:44:59 AM ET
    $ELF
    Package Goods/Cosmetics
    Consumer Discretionary

    Evercore ISI initiated coverage on e.l.f. Beauty with a new price target

    Evercore ISI initiated coverage of e.l.f. Beauty with a rating of In-line and set a new price target of $68.00

    4/2/26 8:09:51 AM ET
    $ELF
    Package Goods/Cosmetics
    Consumer Discretionary

    Deutsche Bank initiated coverage on AtaiBeckley with a new price target

    Deutsche Bank initiated coverage of AtaiBeckley with a rating of Buy and set a new price target of $12.00

    3/27/26 8:46:10 AM ET
    $ATAI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABAT
    $ABIO
    $ACOR
    $ADXN
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for PONVORY issued to VANDA PHARMS INC

    Submission status for VANDA PHARMS INC's drug PONVORY (SUPPL-6) with active ingredient PONESIMOD has changed to 'Approval' on 06/05/2024. Application Category: NDA, Application Number: 213498, Application Classification: Labeling

    6/17/24 12:07:18 AM ET
    $VNDA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for PONVORY issued to VANDA PHARMS INC

    Submission status for VANDA PHARMS INC's drug PONVORY (SUPPL-5) with active ingredient PONESIMOD has changed to 'Approval' on 06/05/2024. Application Category: NDA, Application Number: 213498, Application Classification: Labeling

    6/17/24 12:07:18 AM ET
    $VNDA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for FANAPT issued to VANDA PHARMS INC

    Submission status for VANDA PHARMS INC's drug FANAPT (SUPPL-23) with active ingredient ILOPERIDONE has changed to 'Approval' on 04/02/2024. Application Category: NDA, Application Number: 022192, Application Classification: Efficacy

    4/3/24 4:12:36 PM ET
    $VNDA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABAT
    $ABIO
    $ACOR
    $ADXN
    Financials

    Live finance-specific insights

    View All

    Quhuo Reports Financial Results for the Second Half and Full Year 2025

    BEIJING, April 2, 2026 /PRNewswire/ -- Quhuo Limited (NASDAQ:QH) ("Quhuo," the "Company," "we" or "our"), a leading gig economy platform focusing on local life services in China, today reported its unaudited financial results for the six months and full year ended December 31, 2025. Financial and Operational Highlights for the Second Half of 2025Revenues from housekeeping and accommodation solutions and other services were RMB45.7 million (US$6.5 million), representing a year-over-year increase of 99.8% from RMB22.9 million.Gross profit of vehicle export solutions was RMB12.6 million (US$1.8 million), representing a year-over-year increase of 327.9% from RMB2.9 million.Gross profit of housek

    4/2/26 4:10:00 PM ET
    $QH
    Real Estate

    Lands' End and WHP Global Complete Joint Venture to Accelerate Global Brand Expansion and Unlock Significant Stockholder Value

    JV will accelerate expansion of Lands' End's growth into new categories, channels, and internationally, by leveraging WHP Global's best-in-class platform $300M in gross proceeds to Lands' End enables full repayment of term loan debt, greatly reducing interest expense and significantly strengthening the Company's balance sheet to deliver strategic flexibility and optionality to enhance stockholder value Lands' End stockholders have additional upside opportunity through potential exchange of Lands' End's interest in Joint Venture for equity in WHP Global In a separate press release, WHP Global announced the completion of a Tender Offer for approximately $100 million of Lands' End shares at

    4/1/26 9:00:00 AM ET
    $LE
    Clothing/Shoe/Accessory Stores
    Consumer Discretionary

    Cal-Maine Foods Reports Third Quarter Fiscal 2026 Results

    RIDGELAND, Miss., April 01, 2026 (GLOBE NEWSWIRE) -- Cal-Maine Foods, Inc. (NASDAQ:CALM) ("Cal-Maine Foods," "we," "us," "our" or the "company"), the largest egg company in the United States and a leading player in the egg-based food industry, today reported results for its fiscal 2026 third quarter, ended February 28, 2026. Unless otherwise indicated, all comparisons are to the comparable period of fiscal 2025. Strategic Execution Highlights Continued focus on sales diversification and mix shift, expected to strengthen earnings durability and predictability over timeIn the third quarter of fiscal 2026: Specialty eggs sales increased to 50.5% of total shell egg sales, up 2,610 basis poin

    4/1/26 6:00:00 AM ET
    $CALM
    Farming/Seeds/Milling
    Consumer Staples

    $ABAT
    $ABIO
    $ACOR
    $ADXN
    Leadership Updates

    Live Leadership Updates

    View All

    Intel Appoints Aparna Bawa as Executive Vice President and Chief Legal & People Officer

    Intel Corporation today announced the appointment of Aparna Bawa as EVP, chief legal & people officer. Bawa will report directly to CEO Lip-Bu Tan and will lead Intel's global legal, ethics, compliance, people, and culture organizations as the company accelerates its transformation and execution agenda. "The role of legal and people leadership has never been more critical as Intel drives cultural transformation with discipline, speed, and integrity," said Intel CEO Lip-Bu Tan. "Aparna brings a rare combination of operational rigor, business judgment, and people-first leadership. Her experience helping scale global technology companies through periods of significant change will be invaluab

    4/2/26 4:05:00 PM ET
    $INTC
    Semiconductors
    Technology

    Cal-Maine Foods Welcomes Dudley D. Wooley to Board of Directors

    RIDGELAND, Miss., April 01, 2026 (GLOBE NEWSWIRE) -- Cal-Maine Foods, Inc. (NASDAQ:CALM), the largest egg company in the United States and a leading player in the egg-based food industry, today announced the appointment of Dudley D. Wooley to its Board of Directors. Mr. Wooley brings extensive leadership experience in risk management, business strategy, and governance, further strengthening the Board's depth of expertise as the Company continues executing its long-term growth strategy. Mr. Wooley currently serves as Chief Executive Officer of Ross & Yerger Insurance, Inc., a super-regional, employee-owned independent insurance agency headquartered in Jackson, Mississippi. With more than t

    4/1/26 6:00:00 AM ET
    $CALM
    Farming/Seeds/Milling
    Consumer Staples

    SINTX Technologies Provides Corporate Business Update Highlighting First Human Implant, Strategic Transformation, and Commercial Execution

    Clinical milestone, new President appointment, and platform expansion position SINTX for commercial rollout and revenue growth in 2026 SALT LAKE CITY, Utah, March 23, 2026 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ:SINT) ("SINTX" or the "Company"), an advanced biomaterials company focused on developing silicon nitride technologies for medical applications, today provided a corporate business update highlighting recent clinical, operational, and leadership milestones that the Company believes position it for commercial expansion and future revenue growth. The update follows a series of key developments, including the successful completion of the first human surgical procedure us

    3/23/26 9:15:00 AM ET
    $SINT
    Medical/Dental Instruments
    Health Care

    $ABAT
    $ABIO
    $ACOR
    $ADXN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Mesoblast Limited

    SC 13G/A - MESOBLAST LTD (0001345099) (Subject)

    12/16/24 12:08:07 PM ET
    $MESO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Amendment: SEC Form SC 13D/A filed by Critical Metals Corp.

    SC 13D/A - Critical Metals Corp. (0001951089) (Subject)

    12/13/24 4:10:59 PM ET
    $CRML
    Metal Mining
    Basic Materials

    Amendment: SEC Form SC 13D/A filed by Applied Digital Corporation

    SC 13D/A - Applied Digital Corp. (0001144879) (Subject)

    11/29/24 4:20:07 PM ET
    $APLD
    Finance: Consumer Services
    Finance